// App-Quantinova.ai

: The Impact of Molecular Subtyping on Pathological Staging of Pancreatic Cancer

Researchers

Presenter

  • S. Dreyer

Principal Investigators

  • S. Rae

  • R. Upstill-Goddard

  • A. Johns

  • A. Pea

  • A. Pulvirenti

  • A. Biankin

  • D. Chang

  • N. Jamieson

Medical Centers

  • University of Glasgow, Institute of Cancer Sciences, Glasgow, United Kingdom

  • Garvan Institute of Medical Research, The Kinghorn Cancer Centre, Australia

  • IRCCS Humanitas Hospital, Pancreatic Surgery Unit, Italy

Locations

  • United Kingdom

  • Italy

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreato-biliary malignancies

  • Microphthalmia, syndromic, 9

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final